The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125847372 12584737 2 F 2016 20160728 20160722 20160805 EXP DE-009507513-1607DEU007867 MERCK 79.00 YR F Y 60.00000 KG 20160805 CN DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125847372 12584737 1 PS JANUVIA SITAGLIPTIN PHOSPHATE 1 Oral UNK Y 21995 FILM-COATED TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125847372 12584737 1 Type 2 diabetes mellitus

Outcome of event

Event ID CASEID OUTC COD
125847372 12584737 OT
125847372 12584737 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125847372 12584737 Activated partial thromboplastin time prolonged
125847372 12584737 Acute myocardial infarction
125847372 12584737 Atrial fibrillation
125847372 12584737 Blood glucose increased
125847372 12584737 Coronary artery disease
125847372 12584737 Haematocrit decreased
125847372 12584737 Haemoglobin decreased
125847372 12584737 Mitral valve incompetence
125847372 12584737 Pancreatitis chronic
125847372 12584737 Prothrombin time shortened
125847372 12584737 Pulmonary arterial hypertension
125847372 12584737 Red blood cell count decreased
125847372 12584737 Red cell distribution width increased
125847372 12584737 Restrictive pulmonary disease
125847372 12584737 Reticulocyte count decreased
125847372 12584737 Tricuspid valve incompetence
125847372 12584737 Urinary tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125847372 12584737 1 20160122 20160620 0